In response to an article in the Daily Telegraph published on February 6, MGI would like to point out the following: 1. The article makes factually inaccurate claims. MGI does not produce PCR testing equipment. Also, the NHS and MGI do not have a partnership. 2. As the article itself states, “MGI is not accused of collecting or misusing any genetic data”. We have never collected or misused any genetic data in any of the markets in which we operate, and MGI strenuously rejects any suggestions...

SHENZHEN, China, Feb 7, 2021-- Shenzhen Life Science and Technology University-Industry-Institute Alliance released the industry’s first “Specifications of Remote Robotic Ultrasound Systems for COVID-19 Diagnosis”, (referred to as the Specifications), providing technical references for institutions applying robotic ultrasound diagnosis in COVID-19 diagnosis. The First Specifications of Remote Robotic Ultrasound Systems for COVID-19 Diagnosis Compared with the traditional ultrasound e...

The COVID-19 pandemic is still testing the world in 2021. On January 26th, MGI delivered an automated and integrated nucleic acid testing laboratory (also known as MGI Container Lab) to Medical/Doktor.se, a private clinical group in Sweden. Filip Lind, Business Area Manager at Medical/Doktor.se, said, “In addition to providing packages for COVID testing, the automated & integrated testing laboratory also offers a series of packages to detect other viruses, making it worthy of long-term i...

HAIKOU, CHINA, January 28, 2021--MGI’s "mobile nucleic acid testing and gene sequencing" platform starts operation in Haikou, Hainan province. The two laboratories, namely the Container Sequencing Lab, can be used either separately or together. It can provide large-scale nucleic acid testing for Haikou, but also help to decode whole genome sequence of the coronavirus, contributing to the local pandemic control during the Chinese spring festival. There is a higher probability of mutations...

In response to the ruling of the Patents Court within the High Court of Justice for England & Wales on 20 January 2021, MGI makes the following statement: We concur with the court's ruling that Illumina’s European Patent (EP) 1 828 412 to methods of sequencing by synthesis using ascorbic acid is invalid for obviousness and that MGI’s CoolMPS sequencing method does NOT infringe this patent, and also the finding that MGI’s CoolMPS sequencing does NOT infringe the EP 2 021 415 to a linker...

MGI’s engineer, LV Shuai, also an expectant father, works so hard and hardly has time to take care of his wife in the third trimester of her pregnancy. After receiving the assignment to support the Shijiazhuang outbreak control LV Shuai leaves for Shijiazhuang as soon as possible. MGI First Introduces its High-throughput Automated Nucleic Acid Extractor “MGISTP-7000 can automatically complete barcode scanning, information verification, tube uncapping, liquid transfer and tube recappin...